Reports for PENDOPHARM DIVISION OF PHARMASCIENCE INC
Company Name
PENDOPHARM DIVISION OF PHARMASCIENCE INC
Totals |
||
Shortage reports |
127 |
|
| Actual shortage: | 14 (11%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (4%) | |
| Resolved: | 108 (85%) | |
Discontinuation Reports |
3 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (67%) | |
| Reversed: | 1 (33%) | |
Late reports |
17 (13%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| XYLAC | 25MG | TABLET | Avoided shortage | 2017-07-26 | 2017-10-05 | 17288 |
| XYLAC | 25MG | TABLET | Resolved | 2024-03-19 | 2024-11-14 | 222737 |
| XYLAC | 50MG | TABLET | Actual shortage | 2017-04-04 | 2018-12-22 | 5448 |
| XYLAC | 2.5MG | TABLET | Resolved | 2017-06-12 | 2017-10-05 | 12630 |
| XYLAC | 2.5MG | TABLET | Resolved | 2017-08-15 | 2017-10-05 | 19370 |
| XYLAC | 2.5MG | TABLET | Resolved | 2024-02-22 | 2024-05-10 | 220293 |
| XYLAC | 2.5MG | TABLET | Resolved | 2024-07-11 | 2024-09-23 | 232696 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IBAVYR | 400MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182029 |
| IBAVYR | 200MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182060 |
| OCPHYL | 500MCG | SOLUTION | Reversed | 2017-04-10 | 2017-04-10 | 6237 |
Showing 1 to 3 of 3